銘科精技(001319.SZ):暫不受美國加徵關税政策的影響
格隆匯4月7日丨銘科精技(001319.SZ)在投資者互動平台表示,目前公司核心工藝技術自主可控,無美國引進技術。公司國際業務主要為模具業務,主要市場為亞洲、南美、歐洲等地區,在美國地區銷售的模具較少,與此同時公司從海外進口的模具標準件佔比極少,且國內有同類替代產品;此外,公司衝壓件及總成業務主要圍繞國內合資汽車廠商和新能源汽車廠商做產業配套,基本不受國外市場的影響。目前公司存量業務及在手訂單充足且持續,暫不受美國加徵關税政策的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.